{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T21:08:10Z","timestamp":1786396090646,"version":"build-2736575974"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["GPP 2022"],"award-info":[{"award-number":["GPP 2022"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jaip.2025.10.051","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:14:41Z","timestamp":1763828081000},"page":"599-610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Early Diagnosis and Treatment in Patients With Eosinophilic Granulomatosis With Polyangiitis"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3770-7870","authenticated-orcid":false,"given":"Salman H.","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Wilson-Morkeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.10.051_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2025.10.051_bib2","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1093\/rheumatology\/keab027","article-title":"Heart disease in eosinophilic granulomatosis with polyangiitis (EGPA) patients: a screening approach proposal","volume":"60","author":"Garcia-Vives","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2025.10.051_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11926-022-01087-1","article-title":"At the heart of eosinophilic granulomatosis with polyangiitis: into cardiac and vascular involvement","volume":"24","author":"Bond","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jaip.2025.10.051_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejim.2016.09.014","article-title":"Comprehensive evaluation of cardiac involvement in eosinophilic granulomatosis with polyangiitis (EGPA) with cardiac magnetic resonance","volume":"39","author":"Cereda","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaip.2025.10.051_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management","volume":"26","author":"Groh","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaip.2025.10.051_bib6","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.10.051_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.alit.2019.06.004","article-title":"Update on eosinophilic granulomatosis with polyangiitis","volume":"68","author":"Furuta","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2025.10.051_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2025.10.051_bib9","doi-asserted-by":"crossref","first-page":"iii84","DOI":"10.1093\/rheumatology\/kez570","article-title":"Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management","volume":"59","author":"Trivioli","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaip.2025.10.051_bib10","article-title":"Eosinophilic granulomatosis with polyangiitis: dissecting the pathophysiology","volume":"8","author":"Fagni","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2025.10.051_bib11","article-title":"Eosinophilic granulomatosis with polyangiitis: advances in pathogenesis, diagnosis, and treatment","volume":"10","author":"Fijolek","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2025.10.051_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.10.051_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaip.2025.10.051_bib14","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/rheumatology\/kes171","article-title":"Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients","volume":"51","author":"Jakiela","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2025.10.051_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0","article-title":"Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome","volume":"44","author":"Kiene","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2025.10.051_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/mi.2009.134","article-title":"The influence of TSLP on the allergic response","volume":"3","author":"Comeau","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaip.2025.10.051_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.alit.2020.02.002","article-title":"The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2025.10.051_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143366","article-title":"A role for IL-33-activated ILC2s in eosinophilic vasculitis","volume":"6","author":"Kotas","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2025.10.051_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/ard.2011.155382","article-title":"IgG4 immune response in Churg-Strauss syndrome","volume":"71","author":"Vaglio","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.10.051_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106933","article-title":"The role of neutrophils in ANCA-associated vasculitis","volume":"270","author":"Prendecki","year":"2024","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaip.2025.10.051_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cei.13515","article-title":"The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy","volume":"202","author":"Trivioli","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"suppl 1","key":"10.1016\/j.jaip.2025.10.051_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000210656","article-title":"Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17","volume":"149","author":"Saito","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.10.051_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2008.03.006","article-title":"MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner","volume":"31","author":"Hoshino","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaip.2025.10.051_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/02770903.2010.551796","article-title":"The course of asthma in Churg-Strauss syndrome","volume":"48","author":"Szczeklik","year":"2011","journal-title":"J Asthma"},{"key":"10.1016\/j.jaip.2025.10.051_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MLG.0b013e318159889d","article-title":"Nasal polyposis in Churg-Strauss syndrome","volume":"118","author":"Bacciu","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2025.10.051_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000484602","article-title":"Focus on the involvement of the nose and paranasal sinuses in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): nasal cytology reveals infiltration of eosinophils as a very common feature","volume":"175","author":"Seccia","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.10.051_bib27","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.10.051_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2025.10.051_bib29","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.autrev.2014.08.002","article-title":"Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors","volume":"13","author":"Samson","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaip.2025.10.051_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0b013e3181af35a5","article-title":"Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis","volume":"88","author":"Neumann","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2025.10.051_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2020.12.008","article-title":"Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): prospective evaluation at a tertiary referral centre","volume":"85","author":"Zampieri","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaip.2025.10.051_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/rheumatology\/keaa416","article-title":"Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases","volume":"60","author":"Durel","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2025.10.051_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","volume":"84","author":"Pagnoux","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2025.10.051_bib34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","article-title":"Eosinophils in vasculitis: characteristics and roles in pathogenesis","volume":"10","author":"Khoury","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaip.2025.10.051_bib35","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-019-12515-9","article-title":"Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status","volume":"10","author":"Lyons","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2025.10.051_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103219","article-title":"Eosinophilic granulomatosis with polyangiitis: a review","volume":"22","author":"White","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaip.2025.10.051_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/all.12088","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art","volume":"68","author":"Vaglio","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.10.051_bib38","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2025.10.051_bib39","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaip.2025.10.051_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.10.051_bib41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr2.11263","article-title":"Clinical manifestations and long-term outcomes of eosinophilic granulomatosis with polyangiitis in North America","volume":"3","author":"Doubelt","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jaip.2025.10.051_bib42","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","article-title":"A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients","volume":"72","author":"Moosig","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.10.051_bib43","first-page":"3432","article-title":"Diagnosis and management of eosinophilic granulomatosis with polyangiitis: perspective from the severe asthma clinic","volume":"60","author":"Puan","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.10.051_bib44","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.10.051_bib45","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.10.051_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.anai.2018.05.014","article-title":"Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia","volume":"121","author":"Zimmermann","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.10.051_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mus.27753","article-title":"Diagnostic characteristics of nerve conduction study parameters for vasculitic neuropathy","volume":"67","author":"Davalos","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaip.2025.10.051_bib48","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/thx.54.9.771","article-title":"Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome","volume":"54","author":"Schnabel","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.10.051_bib49","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2015.04.013","article-title":"Impact of cardiac magnetic resonance imaging on eosinophilic granulomatosis with polyangiitis outcomes: a long-term retrospective study on 42 patients","volume":"14","author":"Dunogu\u00e9","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaip.2025.10.051_bib50","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/rheumatology\/keab514","article-title":"Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss)","volume":"61","author":"Sartorelli","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2025.10.051_bib51","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","article-title":"Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease","volume":"38","author":"Caforio","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaip.2025.10.051_bib52","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1398-9995.2012.02873.x","article-title":"Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome","volume":"67","author":"Khoury","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.10.051_bib53","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fimmu.2014.00549","article-title":"Eosinophilic granulomatosis with polyangiitis: an overview","volume":"5","author":"Gioffredi","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2025.10.051_bib54","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.10.051_bib55","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.humpath.2004.05.008","article-title":"Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death","volume":"35","author":"Corradi","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaip.2025.10.051_bib56","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jaci.2023.03.011","article-title":"Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis","volume":"151","author":"Wechsler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.10.051_bib57","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/322707","article-title":"Diagnosis of Strongyloides stercoralis infection","volume":"33","author":"Siddiqui","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2025.10.051_bib58","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(88)91486-9","article-title":"The expanded spectrum of toxocaral disease","volume":"1","author":"Taylor","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.10.051_bib59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.berh.2009.02.004","article-title":"Churg-Strauss angiitis","volume":"23","author":"Sinico","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jaip.2025.10.051_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.iac.2007.07.005","article-title":"Pulmonary eosinophilic syndromes","volume":"27","author":"Wechsler","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.10.051_bib65","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jaip.2017.07.027","article-title":"Rituximab as induction therapy in eosinophilic granulomatosis with polyangiitis refractory to conventional immunosuppressive treatment: a 36-month follow-up analysis","volume":"5","author":"Thiel","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.10.051_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003956","article-title":"Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis","volume":"10","author":"Scherbacher","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.jaip.2025.10.051_bib67","doi-asserted-by":"crossref","first-page":"00509","DOI":"10.1183\/23120541.00509-2023","article-title":"Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics","volume":"10","author":"Jayne","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.10.051_bib68","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.10.051_bib69","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12016-015-8526-3","article-title":"The role and immunobiology of eosinophils in the respiratory system: a comprehensive review","volume":"50","author":"Eng","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.10.051_bib70","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1093\/rheumatology\/keae554","article-title":"Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitis","volume":"64","author":"Padoan","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2025.10.051_bib71","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard-2023-224756","article-title":"Dupilumab for relapsing or refractory sinonasal and\/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study","volume":"82","author":"Molina","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.10.051_bib72","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/rheumatology\/keq400","article-title":"A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis","volume":"50","author":"Suppiah","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2025.10.051_bib73","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/1744-9987.13824","article-title":"Efficacy of plasma exchange therapy for diffuse alveolar hemorrhage in patients with microscopic polyangiitis","volume":"26","author":"Abe","year":"2022","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaip.2025.10.051_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/IOP.0000000000001202","article-title":"Ophthalmic eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a systematic review of the literature","volume":"35","author":"Akella","year":"2019","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jaip.2025.10.051_bib75","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/art.23198","article-title":"Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients","volume":"58","author":"Ribi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2025.10.051_bib76","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.10.051_bib77","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.22679","article-title":"Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients","volume":"57","author":"Cohen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2025.10.051_bib79","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1745-6215-14-73","article-title":"Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial","volume":"14","author":"Walsh","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.jaip.2025.10.051_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103338","article-title":"Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors","volume":"149","author":"Sorin","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaip.2025.10.051_bib81","article-title":"Benralizumab for treating relapsing or refractory eosinophilic granulomatosis with polyangiitis","year":"2025","journal-title":"NICE recommendation"},{"key":"10.1016\/j.jaip.2025.10.051_bib82","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.clinthera.2011.09.009","article-title":"Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review","volume":"33","author":"Sarnes","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2025.10.051_bib83","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1093\/rheumatology\/keaa134","article-title":"FCGR3B polymorphism predicts relapse risk in eosinophilic granulomatosis with polyangiitis","volume":"59","author":"Alberici","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2025.10.051_bib84","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1093\/rheumatology\/keaf240","article-title":"The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis","volume":"64","author":"Biddle","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2025.10.051_bib85","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/acr2.11571","article-title":"Clinical benefit of mepolizumab in eosinophilic granulomatosis with polyangiitis for patients with and without a vasculitic phenotype","volume":"5","author":"Terrier","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jaip.2025.10.051_bib86","first-page":"A249","article-title":"P235 The diagnostic journey of patients with eosinophilic granulomatosis with polyangiitis (EGPA) in England: a retrospective observational cohort study","volume":"79","author":"Siddiqui","year":"2024","journal-title":"Thorax"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825011201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825011201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:50:36Z","timestamp":1781265036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825011201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213219825011201"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.10.051","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Diagnosis and Treatment in Patients With Eosinophilic Granulomatosis With Polyangiitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.10.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}